Emmaus Life Sciences Inc Net Income per Employee (EMMAW), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Emmaus Life Sciences Inc   (EMMAW)
 

Emmaus Life Sciences Inc Net Income per Employee

EMMAW's Quarterly Results, Trends, Rankings, Statistics
Emmaus Life Sciences Inc recorded a cumulative net loss of $-7 million during 12 month ending in the fourth quarter 2025.
The Healthcare sector has seen employees of 138 other companies achieving higher income per employee. While Emmaus Life Sciences Inc 's total ranking has deteriorated compared to the previous quarter from to 3697.


What is Income per Employee Ratio?






EMMAW Net Income per Employee (Dec 31 2025)
IV. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
Y / Y Net Income Change - - - - 2626.87 %
Net Income per Employee (TTM) $ -217,091 -102,606 -134,394 -195,545 -105,939
EMMAW's Total Ranking # 3697 # # 3186 # 3295 # 3790
Seq. Net Income Change - - - - -


EMMAW Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 139
Healthcare Sector # 431
Overall Market # 3697

Net Income per Employee Statistics
High Average Low
$ 194,818 $ -346,971 $ -1,661,879
(Jun 30 2019)   (Dec 31 2019)







Companies with similar Income per Employee for 12 month ending Dec 31 2025, within Healthcare Sector Income per Employee Income 12 month ending Dec 31 2025Number of Employees Dec 31 2025


Date modified: 2026-09-08T15:11:39+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.